Bain Capital Specialty Finance, Inc. Announces 2024 Annual Meeting of Stockholders
Ticker: BCSF · Form: DEF 14A · Filed: Apr 22, 2024 · CIK: 1655050
| Field | Detail |
|---|---|
| Company | Bain Capital Specialty Finance, Inc. (BCSF) |
| Form Type | DEF 14A |
| Filed Date | Apr 22, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.001, $25,000, $10,000, $50,001, $100,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: Proxy Statement, Annual Meeting, Director Election, Stock Sale, Net Asset Value
TL;DR
<b>Bain Capital Specialty Finance, Inc. will hold its 2024 Annual Meeting on May 23, 2024, with key proposals including director elections and authorization to sell stock below NAV.</b>
AI Summary
Bain Capital Specialty Finance, Inc. (BCSF) filed a Proxy Statement (DEF 14A) with the SEC on April 22, 2024. The 2024 Annual Meeting of Stockholders for Bain Capital Specialty Finance, Inc. will be held on May 23, 2024, at 2:30 p.m. ET. Stockholders can participate, vote, and submit questions via live webcast by registering at www.proxydocs.com/BCSF. Key proposals include the election of three Class II Directors for a three-year term. The company seeks authorization to sell common stock below net asset value per share within the next 12 months. Approval for potential adjournment of the meeting to solicit additional proxies is also requested.
Why It Matters
For investors and stakeholders tracking Bain Capital Specialty Finance, Inc., this filing contains several important signals. The election of directors is a standard governance procedure, but the specific class and term length are important for understanding board continuity. The proposal to sell shares below net asset value is a critical decision that could impact existing shareholders' equity and dilution.
Risk Assessment
Risk Level: low — Bain Capital Specialty Finance, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational performance data presented.
Analyst Insight
Review the director nominees and the specific terms of the proposed stock sale authorization to assess potential impacts on shareholder value.
Key Numbers
- May 23, 2024 — Annual Meeting Date (2024 Annual Meeting of Stockholders)
- 2:30 p.m. ET — Annual Meeting Time (2024 Annual Meeting of Stockholders)
- 3 — Directors to Elect (Elect three Class II Directors)
- 3-year term — Director Term Length (Directors will serve for a three-year term)
- 12 months — Stock Sale Authorization Period (During the next 12 months following such stockholder authorization)
Key Players & Entities
- Bain Capital Specialty Finance, Inc. (company) — Registrant and Company Name
- May 23, 2024 (date) — Date of Annual Meeting
- 2:30 p.m. Eastern Time (time) — Time of Annual Meeting
- www.proxydocs.com/BCSF (url) — Registration URL for Annual Meeting
- Class II Directors (director) — Directors to be elected
- 2027 (date) — Term expiration year for directors
FAQ
When did Bain Capital Specialty Finance, Inc. file this DEF 14A?
Bain Capital Specialty Finance, Inc. filed this Proxy Statement (DEF 14A) with the SEC on April 22, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Bain Capital Specialty Finance, Inc. (BCSF).
Where can I read the original DEF 14A filing from Bain Capital Specialty Finance, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Bain Capital Specialty Finance, Inc..
What are the key takeaways from Bain Capital Specialty Finance, Inc.'s DEF 14A?
Bain Capital Specialty Finance, Inc. filed this DEF 14A on April 22, 2024. Key takeaways: The 2024 Annual Meeting of Stockholders for Bain Capital Specialty Finance, Inc. will be held on May 23, 2024, at 2:30 p.m. ET.. Stockholders can participate, vote, and submit questions via live webcast by registering at www.proxydocs.com/BCSF.. Key proposals include the election of three Class II Directors for a three-year term..
Is Bain Capital Specialty Finance, Inc. a risky investment based on this filing?
Based on this DEF 14A, Bain Capital Specialty Finance, Inc. presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational performance data presented.
What should investors do after reading Bain Capital Specialty Finance, Inc.'s DEF 14A?
Review the director nominees and the specific terms of the proposed stock sale authorization to assess potential impacts on shareholder value. The overall sentiment from this filing is neutral.
How does Bain Capital Specialty Finance, Inc. compare to its industry peers?
Bain Capital Specialty Finance, Inc. operates as a business development company (BDC) that invests in debt and equity of middle-market companies. This filing is a routine proxy statement for its annual shareholder meeting.
Are there regulatory concerns for Bain Capital Specialty Finance, Inc.?
As a registered investment company, BCSF is subject to SEC regulations governing proxy solicitations and shareholder meetings, as outlined in Schedule 14A.
Risk Factors
- Authorization to Sell Shares Below NAV [medium — regulatory]: The company seeks authorization to sell common stock below its then-current net asset value per share, subject to limitations, which could impact shareholder equity.
Industry Context
Bain Capital Specialty Finance, Inc. operates as a business development company (BDC) that invests in debt and equity of middle-market companies. This filing is a routine proxy statement for its annual shareholder meeting.
Regulatory Implications
As a registered investment company, BCSF is subject to SEC regulations governing proxy solicitations and shareholder meetings, as outlined in Schedule 14A.
What Investors Should Do
- Review the biographies and qualifications of the proposed Class II Directors.
- Analyze the potential implications and limitations of authorizing the sale of stock below Net Asset Value.
- Understand the process and requirements for registering to attend and participate in the virtual Annual Meeting.
Key Dates
- 2024-05-23: Annual Meeting of Stockholders — Key proposals to be voted on, including director elections and stock sale authorization.
- 2027: Director Term Expiration — Expiration of the three-year term for newly elected Class II Directors.
Year-Over-Year Comparison
This is the definitive proxy statement for the 2024 Annual Meeting, following the typical annual filing cycle for such events.
Filing Stats: 4,681 words · 19 min read · ~16 pages · Grade level 12.5 · Accepted 2024-04-22 16:00:04
Key Financial Figures
- $0.001 — ompany’s common stock, par value $0.001 per share (the “Common Stock
- $25,000 — proxy solicitation are estimated to be $25,000, which will be paid by the Company, and
- $10,000 — e solicitation will total approximately $10,000. VOTING INFORMATION Record Date and
- $50,001 — ) Independent Directors Amy Butte $50,001 - $100,000 David G. Fubini None T
- $100,000 — ndent Directors Amy Butte $50,001 - $100,000 David G. Fubini None Thomas A. Ho
Filing Documents
- bcsf_-_2024_final_proxy.htm (DEF 14A) — 688KB
- img31441731_0.jpg (GRAPHIC) — 1360KB
- img31441731_1.jpg (GRAPHIC) — 103KB
- 0000950170-24-046408.txt ( ) — 2701KB
Security Ownership of Certain Beneficial Owners and Management
Security Ownership of Certain Beneficial Owners and Management The following table sets forth certain ownership information with respect to shares of Common Stock, as of the Record Date, for each of our current Directors, nominees and executive officers, for our Directors and executive officers as a group and for each person known to us to beneficially own more than 5% of the outstanding shares of our Common Stock. With respect to persons known to us to beneficially own more than 5% of the outstanding shares of our Common Stock, we base such knowledge on beneficial ownership filings made by the holders with the Securities and Exchange Commission (“SEC”) and other information known to the Company. Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities. There is no Common Stock subject to options that are currently exercisable or exercisable within 60 days of the Record Date. The percentage ownership is based on 64,562,265.27 shares of Common Stock outstanding as of the Record Date. Unless otherwise indicated, to our knowledge, each stockholder listed below has sole voting and investment power with respect to the shares owned by the stockholder and maintains an address c/o Bain Capital Specialty Finance, Inc. at 200 Clarendon Street, 37 th Floor, Boston, MA 02116. Name and Address Nature of Beneficial Ownership Shares Beneficially Owned Percentage Beneficial Owners of More Than 5% Bank of America Corporation (1) Beneficial 4,107,880 6.40 % Dimension Capital Management LLC (2) Beneficial 4,316,097 6.70 % Bain Capital Distressed and Special Situations 2016 (F), L.P. (3) Record 9,914,820 15.36 % Bain Capital Credit Member, LLC Beneficial 11,822,433 18.31 % Independent Directors Amy Butte Beneficial 6,246 * David G. Fubini N/A — — Thomas A. Hough Beneficial 34,212 * Jay Ma